NCT04069143View on ClinicalTrials.gov

A Study to Evaluate the Safety, Tolerability, Kinetics and Repeatability of 18F-BMS-986327

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

July 12, 2022

Study Completion Date

July 12, 2022

Conditions
Healthy ParticipantsIdiopathic Pulmonary Fibrosis (IPF)
Interventions
DIAGNOSTIC_TEST

18F-BMS-986327

Imaging Agent

Trial Locations (1)

06520-8048

Local Institution - 0001, New Haven

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY